Intema Solutions Inc (ITMZF) 0.0429 $ITMZF Intema Passes

New Post Public Reply Private Reply Replies (0) Message Board

Sep 19, 2016 at 11:22 PM

Intema Solutions Inc (ITMZF) 0.0429 $ITMZF

Intema Passes the 5000 Plus Break Through of New eFlyerMaker Customers
Marketwired - Thu Sep 01, 6:29AM CDT
MONTREAL, QUEBEC--(Marketwired - Sep 1, 2016) - Intema Solutions Inc. ("Intema" or the "Corporation"

(TSX VENTURE:ITM) announced today that its new customer acquisition growth rate is still augmenting at an extreme rate and has passed the 5000 barrier to reach 5015 new eFlyerMaker customers.
ITM.VN: 0.055 (unch)

INTEMA Provides Update on the Closing of its $500,000 Private Placement
Marketwire Canada - Wed Aug 31, 10:30AM CDT
MONTREAL, QUEBEC--(Marketwired - Aug 31, 2016) - Intema Solutions Inc. ("Intema" or the "Corporation"

(TSX VENTURE:ITM) wishes to amend its news release dated August 26, 2016 (the "Closing Date"

announcing the closing of its private placement of 10,000,000 units (the "Units"

at a price of $0.05 per Unit for gross proceeds of $500,000 (the "Private Placement"

to disclose a finder's fee paid in connection with the Private Placement.
ITM.VN: 0.055 (unch)

Intema Completes a Private Placement for a Total of $500,000
Marketwire Canada - Fri Aug 26, 11:36AM CDT
MONTREAL, QUEBEC--(Marketwired - Aug 26, 2016) - Intema Solutions Inc. ("Intema" or the "Corporation"

(TSX VENTURE:ITM). Mr. Roger Plourde, President & CEO, announces that Intema has completed a non-brokered private placement. The Placement consists of a total issuance of 10,000,000 units at a price of $0.05 per unit for gross proceeds of $500,000 (the "Private Placement"

. Each unit consists of one common share and one common share purchase warrant that entitles its holder to subscribe for one common share during a period of two years, at a price of $0.06 after the date of closing of the Private Placement. The securities issued under the Private Placement are subject to a four-month hold period.
ITM.VN: 0.055 (unch)

Intema Maintains Growth Over 182% From the Previous Month With 644 New Customers in May
Marketwire Canada - Thu Jun 09, 6:01AM CDT
MONTREAL, QUEBEC--(Marketwired - Jun 9, 2016) - Intema Solutions Inc. ("Intema" or the "Corporation"

(TSX VENTURE:ITM) announced today that the new customers acquisition growth rate was higher again in May adding a total of 644 new eFlyerMaker customers.
ITM.VN: 0.055 (unch)

Intema Maintains Growth with 144% Increase from the Previous Quarter with 1163 eFlyerMaker Customers
Marketwire Canada - Wed May 04, 10:42AM CDT
MONTREAL, QUEBEC--(Marketwired - May 4, 2016) - Intema Solutions Inc. ("Intema" or the "Corporation"

(TSX VENTURE:ITM) announced today that its marketing program is achieving exceptional results with the addition of 353 new customers in April only. Total number of eFlyerMaker customers on April 30th was 1163.
ITM.VN: 0.055 (unch)

INTEMA Closes $100,000 Private Placement
Marketwired - Tue Apr 19, 2:31PM CDT
INTEMA SOLUTIONS INC. (TSX VENTURE: ITM) ("INTEMA" or the "Corporation"

has closed a brokered private placement of $100,000 in convertible debentures of the Corporation. These debentures mature after two years and are convertible during that time into common shares of the Corporation at a price of $0.05 per common share until April 19, 2017 and $0.10 per common share until April 19, 2018.
ITM.VN: 0.055 (unch)

Intema Adds 350 New Customers in Last Quarter of 2015
Marketwire Canada - Thu Feb 04, 11:29AM CST
Intema Solutions Inc. ("Intema" or the "Corporation"

(TSX VENTURE:ITM), announced today adding a record 356 new customers during the fourth quarter of 2015. The number was up 200% from the prior quarter.
ITM.VN: 0.055 (unch)

BUYINS.NET: XPP, SIMO, SHM, ITM, AGZ, TEAR Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Dec 30, 6:15AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ProShares Ultra FTSE China 25 (NYSE:XPP), Silicon Motion Technology Corp (NASDAQ:SIMO), SPDR Nvn Barclys Cptl Shrt Trm Mncpl Bnd (NYSE:SHM), Intema Solutions Inc (NYSE:ITM), iShares Barclays Agency Bond Fund (NYSE:AGZ), Tearlab Corp (NASDAQ:TEAR) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
XPP: 53.67 (+0.12), TEAR: 0.74 (+0.07), ITM: 24.55 (unch), SHM: 48.85 (-0.04), AGZ: 115.09 (-0.03), SIMO: 50.17 (-0.39)

Intema Solutions Inc. Concludes a Major Agreement for the European Market
Marketwired - Tue Dec 15, 7:10AM CST
Intema Solutions Inc. ("Intema" or the "Corporation"

(TSX VENTURE: ITM), announced today a partnership with Devmar International in Europe for eFlyerMaker(TM) email marketing software.
ITM.VN: 0.055 (unch)

INTEMA Announces $500,000 Offering of Units to Existing Shareholders
Marketwired - Thu Dec 10, 10:18AM CST
Intema Solutions Inc. ("Intema" or the "Corporation"

(TSX VENTURE: ITM) is proposing to raise up to $500,000 by way of a non-brokered private placement (the "Offering"

of up to 25,000,000 units of the Corporation ("Units"

, each Unit consisting of one common share (a "Share"

and one-half of one Share purchase warrant (a "Warrant"

, at a price of $0.02 per Unit. Each Warrant will entitle the holder to purchase one Share at a price of $0.05 per Share for 12 months.
ITM.VN: 0.055 (unch)

INTEMA Moves Forward to a New Market Approach
Marketwired - Wed Oct 28, 10:59AM CDT
Intema Solutions Inc. ("Intema" or the "Corporation"

(TSX VENTURE: ITM). INTEMA informs of an up-date on the company's technologies and marketing strategies.
ITM.VN: 0.055 (unch)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

BETR's Slide: Investors Face Big Losses, Leadership Shift

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...